{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:27:19Z","timestamp":1785342439886,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20224ACB206028"],"award-info":[{"award-number":["20224ACB206028"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20224BAB206071"],"award-info":[{"award-number":["20224BAB206071"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Jiangxi Provincial Department of Education","doi-asserted-by":"publisher","award":["20213BCJL22048"],"award-info":[{"award-number":["20213BCJL22048"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360505"],"award-info":[{"award-number":["82360505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218587","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:16:22Z","timestamp":1778825782000},"page":"218587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["USP48 stabilizes YBX1 to enforce a Wnt-driven stemness circuit and osimertinib resistance in EGFR-mutant NSCLC"],"prefix":"10.1016","volume":"654","author":[{"given":"Kun-Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Kai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Ning","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-9087","authenticated-orcid":false,"given":"Yong-Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218587_bib1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218587_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218587_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218587_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218587_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102557","article-title":"Acquired resistance mechanisms to osimertinib: the constant battle","volume":"116","author":"Zalaquett","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218587_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-Mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218587_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2026.218587_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2020.12.039","article-title":"The impact of osimertinib' line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance","volume":"153","author":"Fuchs","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218587_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218587_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jtho.2023.10.017","article-title":"MUC1-C is a common driver of acquired osimertinib resistance in NSCLC","volume":"19","author":"Haratake","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2026.218587_bib13","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","article-title":"Targeting Wnt signaling: can we safely eradicate cancer stem cells?","volume":"16","author":"Takahashi-Yanaga","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218587_bib14","doi-asserted-by":"crossref","first-page":"djt356","DOI":"10.1093\/jnci\/djt356","article-title":"Wnt signaling pathway in non-small cell lung cancer","volume":"106","author":"Stewart","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2026.218587_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218587_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218587_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218587_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156326","article-title":"USP48 protects against myocardial ischemia-reperfusion injury by stabilizing and upregulating CNN1 in type 1 diabetes mice","volume":"170","author":"Su","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.canlet.2026.218587_bib21","article-title":"Ubiquitin-specific protease 48 drives malignant progression of colorectal cancer by suppressing autophagy through stabilizing sequestosome 1","author":"Li","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218587_bib22","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","article-title":"Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2026.218587_bib23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/sj.onc.1210084","article-title":"Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells","volume":"26","author":"Basaki","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218587_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/path.5030","article-title":"Translational control of aberrant stress responses as a hallmark of cancer","volume":"244","author":"El-Naggar","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218587_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217197","article-title":"YBX1 as a therapeutic target to suppress the LRP1-\u03b2-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer","volume":"602","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218587_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s11658-025-00808-5","article-title":"lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A\/RAP1 activation","volume":"30","author":"Dong","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218587_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ptr.2295","article-title":"Antiviral effects of Glycyrrhiza species","volume":"22","author":"Fiore","year":"2008","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2026.218587_bib28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2026.218587_bib29","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ptr.6178","article-title":"Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review","volume":"32","author":"Pastorino","year":"2018","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2026.218587_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218587_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113772","article-title":"DACT2 modulated by TFAP2A-mediated allelic transcription promotes EGFR-TKIs efficiency in advanced lung adenocarcinoma","volume":"172","author":"Zhang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218587_bib33","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.2147\/OTT.S258896","article-title":"LHX6 affects erlotinib resistance and migration of EGFR-Mutant non-small-cell lung cancer HCC827 cells through suppressing Wnt\/\u03b2-Catenin signaling","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2026.218587_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3689","article-title":"YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT\/\u03b2-catenin axis","volume":"26","author":"Shi","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2026.218587_bib35","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.7150\/thno.41014","article-title":"YB-1 interplays with ER\u03b1 to regulate the stemness and differentiation of ER-positive breast cancer stem cells","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218587_bib36","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing's disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218587_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","article-title":"Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib38","doi-asserted-by":"crossref","first-page":"74872","DOI":"10.18632\/oncotarget.12439","article-title":"Kindlin-2 interacts with \u03b2-catenin and YB-1 to enhance EGFR transcription during glioma progression","volume":"7","author":"Ou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218587_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13402-020-00556-y","article-title":"Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP)","volume":"44","author":"Lou","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2026.218587_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010224","article-title":"Y-Box binding Protein-1 promotes epithelial-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells","volume":"22","author":"Liao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218587_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-025-02285-y","article-title":"NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer","volume":"24","author":"Dai","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib42","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2024.0852","article-title":"Targeting NSCLC drug resistance: systems biology insights into the MALAT1\/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis","volume":"22","author":"Gupta","year":"2025","journal-title":"J. R. Soc., Interface"},{"key":"10.1016\/j.canlet.2026.218587_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-21-3481","article-title":"Antibody-Drug conjugates: a new addition to the treatment landscape of EGFR-Mutant non-small cell lung cancer","volume":"82","author":"Lim","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218587_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2026.218587_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2026.218587_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2026.218587_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified lipid nanoparticles for Tissue- and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2026.218587_bib48","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218587_bib49","article-title":"Consensus on the lung cancer management after third-generation EGFR-TKI resistance","volume":"53","author":"Zhou","year":"2024","journal-title":"Lancet Reg. Health West. Pac."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:55:30Z","timestamp":1783180530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"alternative-id":["S0304383526003502"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218587","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP48 stabilizes YBX1 to enforce a Wnt-driven stemness circuit and osimertinib resistance in EGFR-mutant NSCLC","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218587"}}